Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Recent studies have indicated the existence of tumorigenesis barriers that slow or inhibit the progression of preneoplastic lesions to neoplasia. One such barrier involves DNA replication stress, which leads to activation of the DNA damage checkpoint and thereby to apoptosis or cell cycle arrest, whereas a second barrier is mediated by oncogene-induced senescence. The relationship between these two barriers, if any, has not been elucidated. Here we show that oncogene-induced senescence is associated with signs of DNA replication stress, including prematurely terminated DNA replication forks and DNA double-strand breaks. Inhibiting the DNA double-strand break response kinase ataxia telangiectasia mutated (ATM) suppressed the induction of senescence and in a mouse model led to increased tumour size and invasiveness. Analysis of human precancerous lesions further indicated that DNA damage and senescence markers cosegregate closely. Thus, senescence in human preneoplastic lesions is a manifestation of oncogene-induced DNA replication stress and, together with apoptosis, provides a barrier to malignant progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oncogene activation is a powerful inducer of cellular senescence. Oncogene expression triggers an initial hyperproliferative phase that is intrinsically associated with altered DNA replication, which eventually engages DDR pathways and causes senescence7,8,39”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [8]
In the citing paper
“It has been shown that one mechanism for the link between the initial mitotic reaction and senescence induction is the S-phase-associated DDR: The oncogenic stress drives increased DNA replication origins, leading to accumulation of incomplete replication intermediates, resulting in DNA damage and activation of the DDR kinases (ATM, ATR, CHK2, and CHK1) (Bartkova et al. 2006; Di Micco et al. 2006;”
From Cellular senescence and its effector programs (2014) · cites this paper as Bartkova et al. 2006
In the citing paper
“Colon adenomas, which are stable precursor lesions of invasive colon cancer, were found to be negative for the proliferation marker Ki67 and positive for SA- β- gal 87,88 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [87]
In the citing paper
“colon adenoma- derived samples also have elevated expression of p16 INK4a , HP1γ (an H3K9me3- enriched senescence- associated heterochromatin focus- promoting scaffold that connects H3K9 methyltransferases to Rb as another binding partner), and focal γH2AX expression, indicating enhanced DNA damage 87,89 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [87]
In the citing paper
“In particular, E1A inhibits p53 phosphorylation at serine 15 (14), a hallmark of the activation of the DNA damage response during senescence (3, 12).”
From Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence (2009) · cites this paper as [3]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Self-citationRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Self-citationCrucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
Cited by
Items 201–300 of 1,016
Tigan, A.-S., Bellutti, F., Kollmann, K., Tebb, G., & Sexl, V (2016) · Oncogene · doi:10.1038/onc.2015.407 · Cited by 204
Glucose metabolism in cancer cells
Annibaldi, A., & Widmann, C. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32833a5577 · Cited by 196
Aylon, Y., & Oren, M. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.07.007 · Cited by 190
CKIα ablation highlights a critical role for p53 in invasiveness control
Elyada, E., Pribluda, A., Goldstein, R. E., Morgenstern, Y., Brachya, G., Cojocaru, G., Snir-Alkalay, I., Burstain, I., Haffner-Krausz, R., Jung, S., et al. (2011) · Nature · doi:10.1038/nature09673 · Cited by 197
Mechanisms controlling cell cycle exit upon terminal differentiation
Buttitta, L. A., & Edgar, B. A. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.10.004 · Cited by 201
Liao, H., Ji, F., Helleday, T., & Ying, S. (2018) · EMBO reports · doi:10.15252/embr.201846263 · Cited by 187
Self-citationDNA Damage Responses: Mechanisms and Roles in Human Disease
Kastan, M. B. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0020 · Cited by 189
“In addition, it seems that tumor cells have activated DNA damage and stress response pathways during the transformation process (31, 32), suggesting that these stress response pathways are important for tumor development and growth.”
Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer
Coward, J., & Harding, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00123 · Cited by 192
de Feraudy, S., Revet, I., Bezrookove, V., Feeney, L., & Cleaver, J. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002175107 · Cited by 193
“T maintain the integrity of genomic information under threat of DNA damage, cells employ a range of responses including DNA repair, replication bypass, recombination, cell-cycle checkpoints, and senescence or apoptosis (1, 2).”
BackgroundInfluentialSenescence as a therapeutic target in cancer and age-related diseases
McHugh, D., Durán, I., & Gil, J. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01074-4 · Cited by 197
“Oncogene-induced senesce (OIS) is triggered by the aberrant proliferation caused by oncogene activation, which results in DNA replication stress and a subsequent DNA damage response (DDR) 39,40 .”
Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation
Deschênes-Simard, X., Gaumont-Leclerc, M.-F., Bourdeau, V., Lessard, F., Moiseeva, O., Forest, V., Igelmann, S., Mallette, F. A., Saba-El-Leil, M. K., Meloche, S., et al. (2013) · Genes & Development · doi:10.1101/gad.203984.112 · Cited by 194
Cellular Senescence in Postmitotic Cells: Beyond Growth Arrest
Sapieha, P., & Mallette, F. A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.03.003 · Cited by 193
The ATM signaling network in development and disease
Stracker, T. H., Roig, I., Knobel, P. A., & Marjanović, M. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00037 · Cited by 173
“On the other hand, senescence induced by the overexpression of some oncogenes is dependent upon ATM (Bartkova et al., 2006; Mallette et al., 2007; Efeyan et al., 2009).”
BackgroundA stemness-related ZEB1–MSRB3 axis governs cellular pliancy and breast cancer genome stability
Morel, A.-P., Ginestier, C., Pommier, R. M., Cabaud, O., Ruiz, E., Wicinski, J., Devouassoux-Shisheboran, M., Combaret, V., Finetti, P., Chassot, C., et al. (2017) · Nature Medicine · doi:10.1038/nm.4323 · Cited by 186
Carruthers, R. D., Ahmed, S. U., Ramachandran, S., Strathdee, K., Kurian, K. M., Hedley, A., Gomez-Roman, N., Kalna, G., Neilson, M., Gilmour, L., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0569 · Cited by 176
“RS has previously been implicated in the evolution of GBM and other cancers, particularly with regard to oncogene-induced senescence and as an anticancer barrier in early tumorigenesis (14, 47-49).”
BackgroundOncogenes induce genotoxic stress by mitotic processing of unusual replication intermediates
Neelsen, K. J., Zanini, I. M. Y., Herrador, R., & Lopes, M. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201212058 · Cited by 188
“Whereas the former event marks sites of DNA damage in general, the latter is more specific for DSBs (de Feraudy et al., 2010; Ray progression is controversial and the underlying mechanisms remained elusive (Beck et al., 2010; Domínguez-Kelly et al., 2011; Forment et al., 2011; Murfuni et al., 2013).”
BackgroundOzeri-Galai, E., Lebofsky, R., Rahat, A., Bester, A. C., Bensimon, A., & Kerem, B. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.019 · Cited by 174
Assessing cell and organ senescence biomarkers
de Jesus, B. B., & Blasco, M. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.247866 · Cited by 187
Majumder, P. K., Grisanzio, C., O'Connell, F., Barry, M., Brito, J. M., Xu, Q., Guney, I., Berger, R., Herman, P., Bikoff, R., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.002 · Cited by 178
The causes of replication stress and their consequences on genome stability and cell fate
Magdalou, I., Lopez, B. S., Pasero, P., & Lambert, S. A. E. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.04.035 · Cited by 161
Tumor Stroma-Derived TGF-β Limits Myc-Driven Lymphomagenesis via Suv39h1-Dependent Senescence
Reimann, M., Lee, S., Loddenkemper, C., Dörr, J. R., Tabor, V., Aichele, P., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.043 · Cited by 184
Maya-Mendoza, A., Ostrakova, J., Kosar, M., Hall, A., Duskova, P., Mistrik, M., Merchut-Maya, J. M., Hodny, Z., Bartkova, J., Christensen, C., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2014.11.001 · Cited by 176
“For example, overexpression of cyclin E accelerates S phase entry and induces DNA replication stress and ensuing DNA damage by enhancing replication initiation and impairing fork progression (Bartkova et al., 2005, 2006; Jones et al., 2013).”
BackgroundInfluentialOncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR
Schoppy, D. W., Ragland, R. L., Gilad, O., Shastri, N., Peters, A. A., Murga, M., Fernandez-Capetillo, O., Diehl, J. A., & Brown, E. J. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58928 · Cited by 182
Stable Cellular Senescence Is Associated with Persistent DDR Activation
Fumagalli, M., Rossiello, F., Mondello, C., & d’Adda di Fagagna, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110969 · Cited by 183
ATR signaling can drive cells into senescence in the absence of DNA breaks
Toledo, L. I., Murga, M., Gutierrez-Martinez, P., Soria, R., & Fernandez-Capetillo, O. (2008) · Genes & Development · doi:10.1101/gad.452308 · Cited by 183
“Recent data have suggested that oncogene-induced senescence is linked to an activation of the DDR due to the generation of “replicative stress” (Bartkova et al. 2006; Di Micco et al. 2006).”
BackgroundSenescence-Associated β-Galactosidase Detection in Pathology
Valieva, Y., Ivanova, E., Fayzullin, A., Kurkov, A., & Igrunkova, A. (2022) · Diagnostics · doi:10.3390/diagnostics12102309 · Cited by 182
“Colon adenoma 59 Cells of colon adenomas A strong correlation between SA-β-gal staining and senescence immunohistochemical markers [28]”
BackgroundSenescence Regulation by the p53 Protein Family
Qian, Y., & Chen, X. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_3 · Cited by 171
Adams, P. D. (2007) · Gene · doi:10.1016/j.gene.2007.04.020 · Cited by 176
Thomas, A., Takahashi, N., Rajapakse, V. N., Zhang, X., Sun, Y., Ceribelli, M., Wilson, K. M., Zhang, Y., Beck, E., Sciuto, L., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.02.014 · Cited by 173
“DNA damage resulting from unabated replication – referred to as DNA replication stress – is a major source of genomic instability in cancers and precancerous lesions (Bartkova et al., 2005; Bartkova et al., 2006; Gorgoulis et al., 2005; Zeman and Cimprich, 2014).”
BackgroundThe DNA Damaging Revolution: PARP Inhibitors and Beyond
Yap, T. A., Plummer, R., Azad, N. S., & Helleday, T. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_238473 · Cited by 177
Self-citationTao, Y., Kang, B., Petkovich, D. A., Bhandari, Y. R., In, J., Stein-O'Brien, G., Kong, X., Xie, W., Zachos, N., Maegawa, S., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.005 · Cited by 170
Regulation of E2Fs and senescence by PML nuclear bodies
Vernier, M., Bourdeau, V., Gaumont-Leclerc, M.-F., Moiseeva, O., Bégin, V., Saad, F., Mes-Masson, A.-M., & Ferbeyre, G. (2011) · Genes & Development · doi:10.1101/gad.1975111 · Cited by 177
PR-Set7–dependent lysine methylation ensures genome replication and stability through S phase
Tardat, M., Murr, R., Herceg, Z., Sardet, C., & Julien, E. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200706179 · Cited by 169
“Given the importance of deregulated DNA replication in tumorigenesis (Bartkova et al., 2006; Di Micco et al., 2006) and that loss of H4-K20me3 patterns are observed in almost all human cancers (Fraga et al., 2005), it will be interesting to explore whether PR-Set7 is a putative target for cellular…”
BackgroundBurrows, A. E., Smogorzewska, A., & Elledge, S. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009559107 · Cited by 172
“This program is also engaged in response to activated oncogenes, and DNA damage is thought to be the unifying theme among the stimuli that have been shown to induce a senescence phenotype (1, 2).”
BackgroundPaschalaki, K. E., Starke, R. D., Hu, Y., Mercado, N., Margariti, A., Gorgoulis, V. G., Randi, A. M., & Barnes, P. J. (2013) · Stem Cells · doi:10.1002/stem.1488 · Cited by 172
Self-citationp53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal
Zhao, Z., Zuber, J., Diaz-Flores, E., Lintault, L., Kogan, S. C., Shannon, K., & Lowe, S. W. (2010) · Genes & Development · doi:10.1101/gad.1940710 · Cited by 166
“As an example, oncogenic Ras can trigger replication stress, which in some instances activates p53 as part of a fail-safe mechanism that ultimately prevents malignant transformation (Serrano et al. 1997; Bartkova et al. 2006; Gonzalez et al. 2006).”
BackgroundBartkova, J., Hamerlik, P., Stockhausen, M.-T., Ehrmann, J., Hlobilkova, A., Laursen, H., Kalita, O., Kolar, Z., Poulsen, H. S., Broholm, H., et al. (2010) · Oncogene · doi:10.1038/onc.2010.249 · Cited by 171
Self-citationRegulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase
Beck, H., Nähse, V., Larsen, M. S. Y., Groth, P., Clancy, T., Lees, M., Jørgensen, M., Helleday, T., Syljuåsen, R. G., & Sørensen, C. S. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200905059 · Cited by 169
“Furthermore, oncogenes can induce lesions at replica tion forks, and subsequent induction of the DNA damage response occurs early during tumorigenesis and has been proposed to act as a barrier to tumor progression (Bartkova et al., 2006; Di Micco et al., 2006).”
Self-citationExploring the links between cancer and placenta development
Costanzo, V., Bardelli, A., Siena, S., & Abrignani, S. (2018) · Open Biology · doi:10.1098/rsob.180081 · Cited by 166
Mechanisms of Genomic Instability in Breast Cancer
Duijf, P. H. G., Nanayakkara, D., Nones, K., Srihari, S., Kalimutho, M., & Khanna, K. K. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.04.004 · Cited by 167
Real-time in vivo imaging of p16Ink4a reveals cross talk with p53
Yamakoshi, K., Takahashi, A., Hirota, F., Nakayama, R., Ishimaru, N., Kubo, Y., Mann, D. J., Ohmura, M., Hirao, A., Saya, H., et al. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200904105 · Cited by 172
“…lines of evidence suggest that DDRs triggered by hyper–cell proliferation play a key role or roles in the onset of oncogene-induced senescence (Bartkova et al., 2006; Di Micco et al., 2006; Mallette et al., 2007), we next asked whether DDR triggered by hyper–cell proliferation might be…”
Goldstein, I., Marcel, V, Olivier, M., Oren, M., Rotter, V, & Hainaut, P. (2011) · Cancer Gene Therapy · doi:10.1038/cgt.2010.63 · Cited by 167
Roumelioti, F., Sotiriou, S. K., Katsini, V., Chiourea, M., Halazonetis, T. D., & Gagos, S. (2016) · EMBO reports · doi:10.15252/embr.201643169 · Cited by 160
Self-citationGain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint
Kleiblova, P., Shaltiel, I. A., Benada, J., Ševčík, J., Pecháčková, S., Pohlreich, P., Voest, E. E., Dundr, P., Bartek, J., Kleibl, Z., et al. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201210031 · Cited by 170
“…identified oncogene-induced replication stress and DNA breakage that trigger the DDR as an intrinsic barrier against progression of early preinvasive stages of solid tumors to malignant lesions (Bartkova et al., 2005, 2006; Gorgoulis et al., 2005; Di Micco et al., 2006; Halazonetis et al., 2008).”
Effect of atmospheric gas plasmas on cancer cell signaling
Ishaq, M., Evans, M. (., & Ostrikov, K. (. (2014) · International Journal of Cancer · doi:10.1002/ijc.28323 · Cited by 168
Le, O. N. L., Rodier, F., Fontaine, F., Coppe, J., Campisi, J., DeGregori, J., Laverdière, C., Kokta, V., Haddad, E., & Beauséjour, C. M. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00567.x · Cited by 168
“…telomere attrition ⁄ dysfunction (d’Adda di Fagagna et al., 2003; Herbig et al., 2006) and telomere-independent mechanisms such as oxidative stress or the expression of certain oncogenes (Bartkova et al., 2006; Di Micco et al., 2006; Mallette et al., 2007; Matheu et al., 2007; Wang et al., 2009).”
BackgroundNucleotide metabolism, oncogene-induced senescence and cancer
Aird, K. M., & Zhang, R. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.01.017 · Cited by 166
“Indeed, exogenous nucleosides suppress the DDR and also inhibit senescence induced by RRM2 inhibition.”
InfluentialmTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53
Jung, S. H., Hwang, H. J., Kang, D., Park, H. A., Lee, H. C., Jeong, D., Lee, K., Park, H. J., Ko, Y.-G., & Lee, J.-S. (2019) · Oncogene · doi:10.1038/s41388-018-0521-8 · Cited by 166
The genome and epigenome of malignant melanoma
DAHL, C., & GULDBERG, P. (2007) · APMIS · doi:10.1111/j.1600-0463.2007.apm_855.xml.x · Cited by 162
DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer
Kanu, N., Cerone, M. A., Goh, G., Zalmas, L.-P., Bartkova, J., Dietzen, M., McGranahan, N., Rogers, R., Law, E. K., Gromova, I., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-1042-9 · Cited by 165
Tang, Y., Horikawa, I., Ajiro, M., Robles, A. I., Fujita, K., Mondal, A. M., Stauffer, J. K., Zheng, Z.-M., & Harris, C. C. (2013) · Oncogene · doi:10.1038/onc.2012.288 · Cited by 165
Rossiello, F., Herbig, U., Longhese, M. P., Fumagalli, M., & d’Adda di Fagagna, F. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2014.06.009 · Cited by 156
A step-by-step microRNA guide to cancer development and metastasis
Markopoulos, G. S., Roupakia, E., Tokamani, M., Chavdoula, E., Hatziapostolou, M., Polytarchou, C., Marcu, K. B., Papavassiliou, A. G., Sandaltzopoulos, R., & Kolettas, E. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0341-9 · Cited by 161
Self-citationp53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes
Mondal, A. M., Horikawa, I., Pine, S. R., Fujita, K., Morgan, K. M., Vera, E., Mazur, S. J., Appella, E., Vojtesek, B., Blasco, M. A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70355 · Cited by 164
KRAS and BRAF: drug targets and predictive biomarkers
Vakiani, E., & Solit, D. B. (2011) · The Journal of Pathology · doi:10.1002/path.2796 · Cited by 162
DNA Replication Stress and Chromosomal Instability: Dangerous Liaisons
Wilhelm, T., Said, M., & Naim, V. (2020) · Genes · doi:10.3390/genes11060642 · Cited by 173
“Interestingly, it has been shown that CFSs are also involved in DNA damage induction following oncogene activation in early preneoplastic stages of tumor development, indicating that the induction of their instability may be a key step in the tumorigenic process [17,18,30,31].”
BackgroundBorghi, L., Gutzat, R., Fütterer, J., Laizet, Y., Hennig, L., & Gruissem, W. (2010) · The Plant Cell · doi:10.1105/tpc.110.074591 · Cited by 159
Muñoz, D. P., Yannone, S. M., Daemen, A., Sun, Y., Vakar-Lopez, F., Kawahara, M., Freund, A. M., Rodier, F., Wu, J. D., Desprez, P.-Y., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.124716 · Cited by 162
Is homologous recombination really an error-free process?
Guirouilh-Barbat, J., Lambert, S., Bertrand, P., & Lopez, B. S. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00175 · Cited by 146
“…of endogenous replication stresses, DDR activation resulting from spontaneous endogenous replication stress has also been detected in the early stages of carcinogenesis and senescence (Bartkova et al., 2005, 2006; Gorgoulis et al., 2005; Halazonetis et al., 2008; Gorgoulis and Halazonetis, 2010).”
BackgroundTsantoulis, P. K., Kotsinas, A., Sfikakis, P. P., Evangelou, K., Sideridou, M., Levy, B., Mo, L., Kittas, C. N., Wu, X., Papavassiliou, A. G., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210989 · Cited by 176
“The sequence of these events was triggered by oncogenic stimuli, and was collectively defined as oncogene-induced replication stress (RS) (Bartkova et al., 2005, 2006; Gorgoulis et al., 2005; DiMicco et al., 2006).”
BackgroundSelf-citationLi, C., Deng, C., Wang, S., Dong, X. D., Dai, B., Guo, W., Guo, Q., Feng, Y., Xu, H., Song, X., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103059 · Cited by 168
“ATM is a vital sensor of ROS and collaborates with downstream Chk2 to suppress tumorigenesis by inducing cell senescence and apoptosis [45 – 47].”
BackgroundAMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity
Maiani, E., Milletti, G., Nazio, F., Holdgaard, S. G., Bartkova, J., Rizza, S., Cianfanelli, V., Lorente, M., Simoneschi, D., Di Marco, M., et al. (2021) · Nature · doi:10.1038/s41586-021-03422-5 · Cited by 160
Senescence and senotherapeutics: a new field in cancer therapy
Myrianthopoulos, V., Evangelou, K., Vasileiou, P. V. S., Cooks, T., Vassilakopoulos, T. P., Pangalis, G. A., Kouloukoussa, M., Kittas, C., Georgakilas, A. G., & Gorgoulis, V. G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.08.006 · Cited by 160
Self-citationAlimbetov, D. S., Askarova, S., Umbayev, B. A., Davis, T., & Kipling, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061690 · Cited by 168
“During the course of tumorigenesis and tumor progression, nearly all cancer cells disrupt components of the DNA damage response (DDR) pathway [3].”
BackgroundTelomerase, senescence and ageing
Shawi, M., & Autexier, C. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.11.007 · Cited by 172
p57KIP2: “Kip”ing the Cell under Control
Pateras, I. S., Apostolopoulou, K., Niforou, K., Kotsinas, A., & Gorgoulis, V. G. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0317 · Cited by 149
“As we have previously shown, the DNA damage response (DDR) pathway, which is also activated from the earliest stages of cancer (250, 251),”
BackgroundSelf-citationMarangos, P., Stevense, M., Niaka, K., Lagoudaki, M., Nabti, I., Jessberger, R., & Carroll, J. (2015) · Nature Communications · doi:10.1038/ncomms9706 · Cited by 170
“(% o f o oc yt es ) (37) (46) (44) Scattered spindle chromosomes Misaligned chromosomes Normal metaphase plate * (36) (48)”
BackgroundCellular senescence in musculoskeletal homeostasis, diseases, and regeneration
Wan, M., Gray-Gaillard, E. F., & Elisseeff, J. H. (2021) · Bone Research · doi:10.1038/s41413-021-00164-y · Cited by 165
Ock, C.-Y. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i4.302 · Cited by 149
Jia, L., Li, H., & Sun, Y. (2011) · Neoplasia · doi:10.1593/neo.11420 · Cited by 155
Cellular senescence and chromatin structure
Funayama, R., & Ishikawa, F. (2007) · Chromosoma · doi:10.1007/s00412-007-0115-7 · Cited by 171
“2; Bartkova et al. 2006; Di Micco et al. 2006; Mallette et al. 2007).”
Goto, M. (2008) · PubMed · Cited by 184
Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution
Venkatesan, S., Rosenthal, R., Kanu, N., McGranahan, N., Bartek, J., Quezada, S. A., Hare, J., Harris, R. S., & Swanton, C. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy003 · Cited by 151
Li, M., You, L., Xue, J., & Lu, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00522 · Cited by 137
“Loss of ATM or Checkpoint kinase 2 (CHK2) that phosphorylates and activates p53, was not only able to steer clear of the p53-dependent senescence-related growth arrest but also prevent p53-independent secretion of SASP factors (Bartkova et al., 2006; Xue et al., 2007; Rodier et al., 2011).”
BackgroundOncogene- and tumor suppressor gene-mediated suppression of cellular senescence
Larsson, L. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.10.005 · Cited by 175
Inflammatory signaling and cellular senescence
Ren, J.-L., Pan, J.-S., Lu, Y.-P., Sun, P., & Han, J. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.011 · Cited by 148
Extracellular matrix alterations in senescent cells and their significance in tissue homeostasis
Mavrogonatou, E., Pratsinis, H., Papadopoulou, A., Karamanos, N. K., & Kletsas, D. (2019) · Matrix Biology · doi:10.1016/j.matbio.2017.10.004 · Cited by 153
Self-citationTrial Watch: Targeting ATM–CHK2 and ATR–CHK1 pathways for anticancer therapy
Manic, G., Obrist, F., Sistigu, A., & Vitale, I. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1012976 · Cited by 163
Bianco, J. N., Bergoglio, V., Lin, Y., Pillaire, M., Schmitz, A.-L., Gilhodes, J., Lusque, A., Mazières, J., Lacroix‐Triki, M., Roumeliotis, T. I., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08886-8 · Cited by 161
Age‐associated increase in heterochromatic marks in murine and primate tissues
Kreiling, J. A., Tamamori‐Adachi, M., Sexton, A. N., Jeyapalan, J. C., Munoz‐Najar, U., Peterson, A. L., Manivannan, J., Rogers, E. S., Pchelintsev, N. A., Adams, P. D., et al. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2010.00666.x · Cited by 152
“…method to determine the frequency of senescent cells is to score cells that stain positive for DNA damage foci-associated proteins c-H2AX or 53BP1 (Bartkova et al., 2006; Di Micco et al., 2006; Herbig et al., 2006; Jeyapalan et al., 2007; Sedelnikova et al., 2008; Wang et al., 2009; Le et al.,…”
MethodHistone H3.3 and its proteolytically processed form drive a cellular senescence programme
Duarte, L. F., Young, A. R. J., Wang, Z., Wu, H.-A., Panda, T., Kou, Y., Kapoor, A., Hasson, D., Mills, N. R., Ma’ayan, A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6210 · Cited by 152
Cellular Senescence as the Causal Nexus of Aging
Bhatia-Dey, N., Kanherkar, R. R., Stair, S. E., Makarev, E. O., & Csoka, A. B. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00013 · Cited by 146
The ATR barrier to replication-born DNA damage
López-Contreras, A. J., & Fernandez-Capetillo, O. (2010) · DNA Repair · doi:10.1016/j.dnarep.2010.09.012 · Cited by 139
Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities
Sanjiv, K., Hagenkort, A., Calderón‐Montaño, J. M., Koolmeister, T., Reaper, P. M., Mortusewicz, O., Jacques, S. A., Kuiper, R., Schultz, N., Scobie, M., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.12.032 · Cited by 157
Self-citationGenomic instability in induced stem cells
Pasi, C. E., Dereli-Öz, A., Negrini, S., Friedli, M., Fragola, G., Lombardo, A., Van Houwe, G., Naldini, L., Casola, S., Testa, G., et al. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.9 · Cited by 146
Self-citationPateras, I. S., Havaki, S., Nikitopoulou, X., Vougas, K. N., Townsend, P. A., Panayiotidis, M. I., Georgakilas, A. G., & Gorgoulis, V. G. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.011 · Cited by 158
“An intriguing link between ATM and NF-κB was revealed based on an earlier study showing that mouse skin cells bypassed senescence and became more invasive upon ATM inhibition (Bartkova et al., 2006).”
BackgroundSelf-citationEpigenetic clock analyses of cellular senescence and ageing.
Lowe, D., Horvath, S., & Raj, K. (2016) · Oncotarget · doi:10.18632/oncotarget.7383 · Cited by 147
SCF E3 Ubiquitin Ligases as Anticancer Targets
Jia, L., & Sun, Y. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911794519734 · Cited by 165
SOCS1 Links Cytokine Signaling to p53 and Senescence
Calabrese, V., Mallette, F. A., Deschênes‐Simard, X., Ramanathan, S., Gagnon, J., Moores, A., Ilangumaran, S., & Ferbeyre, G. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.044 · Cited by 161
“…ATM and 754 Molecular Cell 36, 754–767, December 11, 2009 ª2009 Elsevier ATR play an essential role in p53 activation, indicating that the DNA damage response links oncogenic activity to the tumor suppression functions of p53 (Bartkova et al., 2006; Di Micco et al., 2006; Mallette et al., 2007a).”
BackgroundIonizing radiation and aging: rejuvenating an old idea
Richardson, R. B. (2009) · Aging · doi:10.18632/aging.100081 · Cited by 139
“The inhibition of tumorigenesis by cellular senescence is oncogene-induced and linked to increased expression of tumor suppressor genes p16 and TP53 via the DNA damage response [117].”
BackgroundThe physiological and pathophysiological role of PRMT1-mediated protein arginine methylation
Nicholson, T. B., Chen, T., & Richard, S. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.07.006 · Cited by 159
Gala, M. K., Mizukami, Y., Le, L. P., Moriichi, K., Austin, T. R., Yamamoto, M., Lauwers, G. Y., Bardeesy, N. M., & Chung, D. C. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.045 · Cited by 159
Oncogenic Activities of IDH1/2 Mutations: From Epigenetics to Cellular Signaling
Gagné, L. M., Boulay, K., Topisirović, I., Huot, M., & Mallette, F. A. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.06.002 · Cited by 152
Biomarkers to identify and isolate senescent cells
Matjusaitis, M., Chin, G., Sarnoski, E. A., & Stolzing, A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.003 · Cited by 144
“Interestingly, cellular senescence can also be induced by stress (Toussaint et al., 2000) and oncogenes (Bartkova et al., 2006), demonstrating that cellular senescence is not only caused by exhaustion of replicative capacity as first thought.”
Leveraging the replication stress response to optimize cancer therapy
Cybulla, E., & Vindigni, A. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00518-6 · Cited by 153
Oncogene-Induced Senescence Pathways Weave an Intricate Tapestry
Yaswen, P., & Campisi, J. (2007) · Cell · doi:10.1016/j.cell.2007.01.005 · Cited by 154
Update on Human Polyomaviruses and Cancer
Gjoerup, O. V., & Chang, Y. (2010) · Advances in cancer research · doi:10.1016/s0065-230x(10)06001-x · Cited by 160
“Later experiments demonstrated that 17k K1 induces a DNA damage response via Bub1 binding (Hein et al., 2009), consistent with recent reports that senescence in general is tied to an activated DNA damage response (Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundMelanoma: Molecular pathogenesis and emerging target therapies (Review)
Libra (2009) · International Journal of Oncology · doi:10.3892/ijo_00000277 · Cited by 136
Davis, Z., Vallera, D. A., Miller, J. S., & Felices, M. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.07.011 · Cited by 150
Heiss, E. H., Schilder, Y. D. C., & Dirsch, V. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703229200 · Cited by 136
Metadata
- Authors
- Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., Takaoka, M., Nakagawa, H., Tort, F., Fugger, K., Johansson, F., Sehested, M., Andersen, C. L., Dyrskjot, L., Ørntoft, T., Lukas, J., Kittas, C., Helleday, T., Halazonetis, T. D., Bartek, J., & Gorgoulis, V. G.
- Affiliations
- The Wistar Institute (US)
- National and Kapodistrian University of Athens (GR)
- National Centre of Scientific Research "Demokritos" (GR)
- Stockholm University (SE)
- University of Ioannina (GR)
- National Hellenic Research Foundation (GR)
- University of Pennsylvania (US)
- Danish Cancer Society (DK)
- Copenhagen University Hospital (DK)
- Aarhus University Hospital (DK)
- Corresponding author
- Halazonetis, Thanos D.
- ORCID
- Venue
- Nature
- Published
- 2006-11
- Volume
- 444
- Issue
- 7119
- Pages
- 633-637
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2041156660
- Cited by
- 1,986
- References
- 30
- Citations by year
- 2026: 35 · 2025: 74 · 2024: 65 · 2023: 92 · 2022: 74 · 2021: 96 · 2020: 88 · 2019: 83 · 2018: 108 · 2017: 100 · 2016: 122 · 2015: 88 · 2014: 134 · 2013: 129 · 2012: 132
- FWCI
- 65.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- National Hellenic Research Foundation Helios Repository (National Hellenic Research Foundation) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- oncogene-induced senescence, DNA damage response, replication stress, DNA double-strand breaks, ATM kinase, precancerous lesions, senescence markers, tumor progression, apoptosis
- MeSH terms
- Animals, Cell Line, Cell Transformation, Neoplastic, DNA, DNA Damage, DNA Replication, Humans, Neoplasm Invasiveness, Nuclear Proteins, Oncogenes, Precancerous Conditions, Genes, mos, Cellular Senescence, Cell Cycle Proteins, Cyclin E, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.